The biotech-verse was buzzing this week after Kite Pharma Inc (NASDAQ:KITE) submitted an IND application for its pipeline cancer drug that sent shares rising. …
Kite Pharma Inc (NASDAQ: KITE) announced that Ian T. Clark, former Chief Executive Officer, Head of Commercial Operations and member of the Board of …
Kite Pharma Inc (NASDAQ: KITE) announced that it has submitted an Investigational New Drug (IND) application with the U.S.
Kite Pharma Inc (NASDAQ: KITE) announced several updates to its broad intellectual property portfolio relating to the use of chimeric antigen receptors (CARs) …
Kite Pharma Inc (NASDAQ:KITE) and Vitruvian Networks, Inc., a pioneering cell and gene therapy software and analytics platform company co-founded by GE Ventures …
Kite Pharma Inc (NASDAQ:KITE) announced that characterizations of T cell receptor candidates which it has licensed under the Cooperative Research and Development Agreement …
Kite Pharma Inc (NASDAQ: KITE) presented results from the ZUMA-1 trial of axicabtagene ciloleucel (KTE-C19) in patients with chemorefractory aggressive non-Hodgkin lymphoma (NHL) …
Kite Pharma Inc (NASDAQ:KITE) announced the appointment of Jian Irish, Ph.D.
Kite Pharma Inc (NASDAQ:KITE) announced the appointment of Chris Nowers as its Head ofEurope. Nowers will be based in London.
EndoChoice Holdings Inc EndoChoice Holdings Inc (NYSE:GI) shares jumped nearly 90% today following the news that Boston Scientific Corporation (NYSE:BSX) will acquire GI for $8.00 …
